news.today
Hello · Register today | LoginHello · My Account[—] [33]
Business

Pharmaceutical firm scraps £58m research facility plan in Bristol

Summarised from 2 outlets · Updated 11 Nov, 06:04 · Archive

Phillips Medisize is selling a Bristol and Bath Science Park site earmarked for a £58 million research facility, focusing instead on its Wiltshire operations.

Phillips Medisize, a subsidiary of medical device maker Molex, is selling a site on the Bristol and Bath Science Park that had been earmarked for a £58 million research facility. The company acquired Wiltshire-based Vectura from Philip Morris International last year. Vectura had secured planning permission in 2022 for the 'state of the art' Inhalation Centre of Excellence at the science park, with a view to opening it in 2025.

Instead of proceeding with the Bristol facility, Phillips Medisize has acquired the complete footprint of its Chippenham site and is expanding its Global Inhalation Centre of Excellence there. The company serves pharmaceutical clients developing treatments for conditions including pulmonary arterial hypertension and other complex diseases requiring advanced inhalation therapy solutions.

Charlie Schumacher, vice president of inhalation therapies at Phillips Medisize, said the company had decided to sell the Bristol site as it continues to focus its investments on 'the expertise, talent and capabilities at its Chippenham and Cambridge facilities, which form the foundation of its inhalation business and future growth strategy.' Schumacher previously said the Chippenham acquisition comes as the company continues to 'track ahead of schedule' and reported feeling 'confident' in its trajectory.

Pharmaceutical firm scraps £58m research facility plan in Bristol
Image: Gazette & Herald

Comments (0)

How it is being reported

In this story: Phillips Medisize · Molex · Vectura · Philip Morris International · Bristol and Bath Science Park · Wiltshire · Chippenham · Cambridge

This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log